<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00931320</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-CKR-DUM-2009/3</org_study_id>
    <nct_id>NCT00931320</nct_id>
  </id_info>
  <brief_title>Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients</brief_title>
  <acronym>RACHEL</acronym>
  <official_title>Investigation Into the RAtio of LDL-CHolestEroL to HDL-Cholesterol Improvement After Statin Treatment in Korean Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      An observational, non-interventional, multi-centre study to provide further information on
      the ratio of LDL-C to HDL-C improvement after statin treatment in Korean patients group.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">September 2009</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate current LDL/HDL ratio in Korean patients (between baseline &amp; after treatment)</measure>
    <time_frame>After Treatment : at least 4 weeks before statin taking /Baseline : no limitation.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate difference of LDL/HDL ratio among different statins &amp; dosages (between baseline &amp; after treatment)</measure>
    <time_frame>After Treatment : at least 4 weeks before statin taking / Baseline : no limitation.</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Dyslipidemias</condition>
  <arm_group>
    <arm_group_label>3000 patients</arm_group_label>
    <description>Who have at least made 1 visit to the outpatient clinic within previous 6 months .</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Who have at least made 1 visit to the outpatient clinic within previous 6 months .
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who are taking lipid-lowering medication after diagnosed as dyslipidaemia

          -  Subjects who have at least made 1 visit to the outpatient clinic within previous 6
             months

          -  Subjects who have records of both LDL-C and HDL-C before &amp; after statin treatment (at
             least four weeks after statin taking)

        Exclusion Criteria:

          -  Subjects who are unwilling or unable to provide their examination and lab result of
             medical chart.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyunah Caroline Choi</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca Korea</affiliation>
  </overall_official>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 30, 2009</study_first_submitted>
  <study_first_submitted_qc>July 1, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 2, 2009</study_first_posted>
  <last_update_submitted>October 23, 2009</last_update_submitted>
  <last_update_submitted_qc>October 23, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2009</last_update_posted>
  <responsible_party>
    <name_title>Hyunah Caroline, Choi / CV TA Physician</name_title>
    <organization>AstraZeneca Pharmaceuticals</organization>
  </responsible_party>
  <keyword>Ratio improvement</keyword>
  <keyword>LDL-C</keyword>
  <keyword>HDL-C</keyword>
  <keyword>Ratio of Low Density Lipoprotein Cholesterol to High Density Lipoprotein Cholesterol Improvement</keyword>
  <keyword>High Density Lipoprotein Cholesterol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyslipidemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

